Marcin Drąg
Impact in
- Oncology top 1%
- Peptidase Inhibition and Analysis
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 15
- Cell death mechanisms and regulation 15
- Chemical Synthesis and Analysis 14
- Oncology 67
- Peptidase Inhibition and Analysis 63
- Co-authors
- Guy S. Salvesen (48 shared papers)Marcin Poręba (54 shared papers)Paulina Kasperkiewicz (32 shared papers)Scott J. Snipas (23 shared papers)Wioletta Rut (32 shared papers)Paweł Kafarski (18 shared papers)Miklós Békés (9 shared papers)Katarzyna Groborz (21 shared papers)
- Journals
- Biochemical Journal (12 papers)Journal of Biological Chemistry (9 papers)Biochimie (8 papers)Journal of Medicinal Chemistry (7 papers)Cell Death and Differentiation (6 papers)
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Marcin Drąg
157 papers receiving 6.4k citations
Marcin Drąg's Hit Papers
Peers
Comparison fields: 5 of 137
- Oncology 1.8k
- Cancer Research 770
- Molecular Biology 3.8k
- Infectious Diseases 784
- Immunology 812
Countries citing papers authored by Marcin Drąg
This map shows the geographic impact of Marcin Drąg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcin Drąg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcin Drąg more than expected).
Fields of papers citing papers by Marcin Drąg
This network shows the impact of papers produced by Marcin Drąg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcin Drąg. The network helps show where Marcin Drąg may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcin Drąg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 478 | |
| 2 | Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design Hit paper breakdown → | 2020 | 362 |
| 3 | 2020 | 218 | |
| 4 | 2011 | 194 | |
| 5 | 2018 | 191 | |
| 6 | 2013 | 163 | |
| 7 | 2014 | 147 | |
| 8 | 2009 | 140 | |
| 9 | 2007 | 132 | |
| 10 | 2010 | 118 | |
| 11 | 2009 | 110 | |
| 12 | 2021 | 103 | |
| 13 | 2008 | 96 | |
| 14 | 2009 | 95 | |
| 15 | 2010 | 93 | |
| 16 | 2009 | 90 | |
| 17 | 2017 | 85 | |
| 18 | 2018 | 83 | |
| 19 | 2017 | 82 | |
| 20 | 2011 | 79 |
About Marcin Drąg
Marcin Drąg is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Immunology, having authored 160 papers that have together received 6.4k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (63 papers), Protease and Inhibitor Mechanisms (20 papers), Ubiquitin and proteasome pathways (15 papers), Cell death mechanisms and regulation (15 papers), Neuropeptides and Animal Physiology (14 papers), Click Chemistry and Applications (14 papers), Chemical Synthesis and Analysis (14 papers) and Organophosphorus compounds synthesis (12 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (770 citations), Molecular Biology (3.8k citations), Infectious Diseases (784 citations) and Immunology (812 citations). Marcin Drąg has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Guy S. Salvesen, Marcin Poręba, Paulina Kasperkiewicz, Scott J. Snipas, Wioletta Rut, Paweł Kafarski, Miklós Békés, Katarzyna Groborz, Mikołaj Żmudziński and Tony T. Huang. Their work appears in journals such as Biochemical Journal, Journal of Biological Chemistry, Biochimie, Journal of Medicinal Chemistry and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.